Clinical Trial Update: Prospective Observational Study Evaluating Treatment Decision Impact of Prosigna® in Early Stage Breast Cancer Patients

View source ↗

Summary

This completed prospective observational study evaluates how results from the Prosigna genomic test influence treatment decisions in patients with early-stage b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: NanoString Technologies, Inc. | Conditions: Breast Cancer | Status: COMPLETED